Local emergence and decline of a SARS-CoV-2 variant with mutations L452R and N501Y in the spike protein
Mallm, J.-P.; Bundschuh, C.; Kim, H.; Weidner, N.; Steiger, S.; Lander, I.; Börner, K.; Bauer, K.; Hübschmann, D.; Benes, V.; Rausch, T.; Trevisan Doimo de Azevedo, N.; Telzerow, A.; Jost, K. L.; Parthe, S.; Schnitzler, P.; Boutros, M.; Müller, B.; Bartenschlager, R.; Kräusslich, H.-G.; Rippe, K.
Show abstract
Variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are replacing the initial wild-type strain, jeopardizing current efforts to contain the pandemic. Amino acid exchanges in the spike protein are of particular concern as they can render the virus more transmissible or reduce vaccine efficacy. Here, we conducted whole genome sequencing of SARS-CoV-2 positive samples from the Rhine-Neckar district in Germany during January-March 2021. We detected a total of 166 samples positive for a variant with a distinct mutational pattern in the spike gene comprising L18F, L452R, N501Y, A653V, H655Y, D796Y and G1219V with a later gain of A222V. This variant was designated A.27.RN according to its phylogenetic clade classification. It emerged in parallel with the B.1.1.7 variant, increased to >50% of all SARS-CoV-2 variants by week five. Subsequently it decreased to <10% of all variants by calendar week eight when B.1.1.7 had become the dominant strain. Antibodies induced by BNT162b2 vaccination neutralized A.27.RN but with a two-to-threefold reduced efficacy as compared to the wild-type and B.1.1.7 strains. These observations strongly argue for continuous and comprehensive monitoring of SARS-CoV-2 evolution on a population level.
Matching journals
The top 11 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Spike independent infection of human coronavirus 229E in bat cells 96%
- Post-vaccination SARS-COV-2 among healthcare workers in New Jersey: a genomic epidemiological study 95%
- Targeted Hybridization Capture of SARS-CoV-2 and Metagenomics Enables Genetic Variant Discovery and Nasal Microbiome Insights 95%
Similar papers in this journal
- High-Throughput, Single-Copy Sequencing Reveals SARS-CoV-2 Spike Variants Coincident with Mounting Humoral Immunity during Acute COVID-19 97%
- Variant-specific humoral immune response to SARS-CoV-2 escape mutants arising in clinically severe, prolonged infection 96%
- Biosynthetic proteins targeting the SARS-CoV-2 spike as anti-virals 96%
Similar papers in this journal
- SARS-CoV-2 variants associated with vaccine breakthrough in the Delaware Valley through summer 2021 96%
- Longitudinal Study after Sputnik V Vaccination Shows Durable SARS-CoV-2 Neutralizing Antibodies and Reduced Viral Variant Escape over Time 96%
- Rescue of SARS-CoV-2 from a single bacterial artificial chromosome 96%
Similar papers in this journal
- Increased resistance of SARS-CoV-2 Omicron Variant to Neutralization by Vaccine-Elicited and Therapeutic Antibodies 96%
- Cross-sectional and longitudinal genotype to phenotype surveillance of SARS-CoV-2 variants over the first four years of the COVID-19 pandemic 95%
- Reduced Neutralization of SARS-CoV-2 Omicron Variant by Vaccine Sera and monoclonal antibodies 95%
Similar papers in this journal
- Emergence and spread of a sub-lineage of SARS-CoV-2 Alpha variant B.1.1.7 in Europe, and with further evolution of spike mutation accumulations shared with the Beta and Gamma variants 97%
- Genome data artifacts and functional studies of deletion repair in the BA.1 SARS-CoV-2 spike protein 97%
- Intra-host evolution during SARS-CoV-2 persistent infection 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.